Enhancing techniques to evaluate tumor margins - 17/09/14
Funding sources: Anna Fund Melanoma Program, Sylvester Comprehensive Cancer Center, Frankel Family Division of Melanocytic Tumors, Department of Dermatology and Cutaneous Surgery, and benefactors, especially William Rubin and his family and friends. |
|
Disclosures: Dr Grichnik has consulted for Roche, Novartis, and Caliber ID and is a DigitalDerm major shareholder. Drs Cao, Jiménez-Acosta, and Elgart, as well as author Sode have no potential conflicts of interest to declare. |
Vol 71 - N° 4
P. 827-829 - octobre 2014 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?